M. R. Corces-Zimmerman
Hematology · 2012–2014
A researcher in the Science corpus: 2 papers; trusts 3 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Hematology — 28 citations into it
Whom M. R. Corces-Zimmerman trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from M. R. Corces-Zimmerman's perspective
Ordered by how strongly the researchers M. R. Corces-Zimmerman trusts endorse each paper. Same corpus, a different order for every researcher.
- Genetic diagnosis by whole exome capture and massively parallel DNA sequencing (Proceedings of the National Academy of Sciences of the United States of America)
- Mutation in TET2 in myeloid cancers. (New England Journal of Medicine)
- CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells (Cell)
- Genetic variegation of clonal architecture and propagating cells in leukaemia (Nature)
- Genomic Analysis of the Clonal Origins of Relapsed Acute Lymphoblastic Leukemia (Science)
- Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. (New England Journal of Medicine)
- Identification of a hierarchy of multipotent hematopoietic progenitors in human cord blood. (Cell Stem Cell)
- Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes (Nature Genetics)
- Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders (Nature Genetics)
- TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis. (Cancer Cell)